The results were historic: participants lost up to 28 The 9 mg group achieved: 26.4% average weight reduction The placebo group: 2.1% average weight reduction According to Lilly, the highest-dose group lost an average of approximately 71.2 pounds
Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis
the FDA approved tirzepatide specifically for type 2 diabetes in 2022 and off-label use for weight management grew thereafter
Screenshots and Data The Markup found 66 listings for peptides available for sale on Amazon in August and September, even though the company bans injectable drugs and told The Markup in May it would start cracking down on peptide listings
Predictors of blood pressure response: obesity is associated with a less pronounced treatment response after renal denervation
As a society, as practitioners, we are completely and entirely ignoring self-experimentation, which is being done at massive scale